This compound is primarily utilized in the synthesis of pharmaceutical intermediates, particularly in the development of central nervous system (CNS) drugs. It serves as a key building block in the creation of compounds that target neurological disorders, such as Parkinson's disease and schizophrenia, due to its structural compatibility with dopamine receptor ligands. Additionally, it is employed in organic chemistry research for the preparation of complex molecules, including chiral catalysts and ligands for asymmetric synthesis. Its benzyl and pyrrolidine groups make it a versatile scaffold for designing molecules with specific biological activities.